Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Glaxosmithkline Plc
Relationship:   10% Owner
City:   Brentford Middlesex
State:   X0
   
Insider Summary:
  
   
Companies Owned :   30    
Direct Shares   0    

Indirect Shares

   354,639,946      
Direct Value   $0    

Indirect Value

   $1,072,030,250      
Total Shares   354,639,946      
Total Value   $1,072,030,250      


                                          Charting Not Avaliable
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    3   
    1    

     Stock price went up :
    2   
    1    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   2.0   
   1.0   
     Percentage Gain/Loss :
   23.6%
 18.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Quest Diagnostics Inc DGX Director, 10% Owner 2004-06-25 0 2011-01-31 0    Premium*  
            Redpoint Bio Corp RPBC 10% Owner 0 2007-03-12 7,456,899    Premium*  
            Maxygen Inc MAXY 10% Owner 2003-08-05 0 2009-12-30 1,433,361    Premium*  
            Amicus Therapeutics Inc FOLD Former 10% Owner (1) 0 2014-10-27 0    Premium*  
            Innoviva Inc INVA 10% Owner 2010-11-29 0 2021-05-20 0    Premium*  
            Chemocentryx, Inc. CCXI Former 10% holder 0 2018-10-16 0    Premium*  
            Human Genome Sciences Inc HGSI Director, 10% Owner 2012-07-30 0 2012-08-02 233,716,708    Premium*  
            Response Genetics Inc RGDX 10% Owner 0 2012-09-13 5,000,000    Premium*  
            Genocea Biosciences, Inc. GNCA 10% Owner 2014-02-10 0 2020-07-24 4,626,389    Premium*  
            Concert Pharmaceuticals, Inc. CNCE Former 10% Owner 2014-02-19 0 2014-02-19 1,356,533    Premium*  
            Applied Genetic Technologies Corp AGTC Former 10% Owner 2014-04-01 0 2015-02-23 1,436,448    Premium*  
            Theravance Biopharma, Inc. TBPH Former 10% Owner 0 2022-09-16 0    Premium*  
            Htg Molecular Diagnostics, Inc HTGM Former 10% Owner 2015-05-11 0 2017-03-27 792,781    Premium*  
            Crispr Therapeutics Ag CRSP 10% Owner 2016-10-24 0 2016-10-24 3,220,627    Premium*  
            Spero Therapeutics Inc SPRO 10% Owner 2017-11-06 0 2022-11-07 9,190,606    Premium*  
            Translate Bio, Inc. TBIO 10% Owner 2018-07-02 0 2018-07-02 3,697,912    Premium*  
            Liquidia Technologies Inc LQDA Former 10% holder 2018-07-30 0 2018-07-30 624,422    Premium*  
            Principia Biopharma Inc PRNB Former 10% Owner 2018-09-18 0 2019-10-18 2,982,855    Premium*  
            Turning Point Therapeutics, Inc. TPTX Director 2019-04-22 0 2020-05-21 2,253,660    Premium*  
            Bicycle Therapeutics Ltd BCYC 10% Owner 2019-05-28 0 2020-07-15 1,910,531    Premium*  
            Morphic Holding, Inc. MORF Director 2019-07-01 0 2019-07-01 2,633,772    Premium*  
            Fulcrum Therapeutics, Inc. FULC 2019-07-22 0 2019-07-22 1,785,714    Premium*  
            Progyny, Inc. PGNY 10% Owner 0 2020-05-20 6,238,244    Premium*  
            Orchard Therapeutics Plc ORTX Director, 10% Owner 0 2020-01-01 12,455,252    Premium*  
            Nkarta, Inc. NKTX Director, 10% Owner 2020-07-14 0 2020-07-14 3,150,732    Premium*  
            Pandion Therapeutics, Inc. PAND Director, 10% Owner 2020-07-21 0 2020-07-21 2,248,304    Premium*  
            Decibel Therapeutics, Inc. DBTX Director 2021-02-17 0 2021-02-17 1,183,663    Premium*  
            Lyell Immunopharma, Inc. LYEL 10% Owner 2021-06-21 0 2021-06-21 30,253,189    Premium*  
            Cvrx, Inc. CVRX 10% Owner 2021-07-02 0 2021-07-02 1,007,583    Premium*  
            Wave Life Sciences Ltd. WVE 10% Owner 0 2023-12-07 13,983,761    Premium*  
* Premium Members only  

Records found :    107         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
DGX Quest Diagnostics Inc Director   –       •       •   2009-03-17 4 S $45.50 $22,749,150 I/I (500,000) 36,004,308 0 -
DGX Quest Diagnostics Inc Director   –       •       •   2009-03-18 4 S $45.67 $22,852,021 I/I (500,000) 35,504,308 0 -
DGX Quest Diagnostics Inc Director   –       •       •   2009-03-19 4 S $44.33 $210,541,912 I/I (4,749,157) 30,755,151 0 -
DGX Quest Diagnostics Inc Director   –       •       •   2011-01-31 4 S $54.30 $1,690,226,243 I/I (30,755,151) 0 0 -
FOLD Amicus Therapeutics Inc 10% Owner   –       –       •   2010-11-12 3 IO $0.00 $0 I/I 0 6,866,244 -
FOLD Amicus Therapeutics Inc 10% Owner   –       –       •   2012-07-17 4 B $6.30 $18,582,360 I/I 2,949,581 9,815,825 1.5 -
FOLD Amicus Therapeutics Inc 10% Owner   –       –       •   2013-11-20 4 B $2.00 $3,000,000 I/I 1,500,000 11,315,825 1.5 -
FOLD Amicus Therapeutics Inc Former 10% Owner (1)   –       –      –    2014-10-27 4 S $5.29 $59,872,030 I/I (11,315,825) 0 0 -
FULC Fulcrum Therapeutics, Inc...   •       •       •   2019-07-22 4 A $0.00 $0 I/I 1,785,714 1,785,714 0 -
GNCA Genocea Biosciences, Inc. Former 10% Shareholder   –       –      –    2014-02-10 4 A $0.00 $0 I/I 1,527,894 1,671,667 0 -
GNCA Genocea Biosciences, Inc. Former 10% Shareholder   –       –      –    2014-02-10 4 B $12.00 $1,725,276 I/I 143,773 143,773 0.01 -
GNCA Genocea Biosciences, Inc. 10% Owner   –       –       •   2019-02-14 3 IO $0.00 $0 I/I 0 12,069,937 -
GNCA Genocea Biosciences, Inc. 10% Owner   –       –       •   2019-06-24 4 B $3.50 $6,499,997 I/I 1,857,142 3,365,884 1.5 -
GNCA Genocea Biosciences, Inc. 10% Owner   –       –       •   2020-07-24 4 B $2.25 $2,836,134 I/I 1,260,504 4,626,389 1.5 -
HGSI Human Genome Sciences Inc Director   –       •       •   2012-07-30 4 B $14.25 $70,320,088 I/I 4,934,743 163,595,621 2.25 -
HGSI Human Genome Sciences Inc Director   –       •       •   2012-07-30 3 IO $0.00 $0 I/I 0 158,660,878 -
HGSI Human Genome Sciences Inc Director   –       •       •   2012-08-01 4 B $14.25 $25,481,651 I/I 1,788,186 165,383,807 2.25 -
HGSI Human Genome Sciences Inc Director   –       •       •   2012-08-01 4 B $14.25 $81,035,689 I/I 5,686,715 171,070,522 2.25 -
HGSI Human Genome Sciences Inc Director   –       •       •   2012-08-02 4 B $14.25 $892,708,151 I/I 62,646,186 233,716,708 2.25 -
HTGM Htg Molecular Diagnostics... 10% Owner   –       –       •   2015-05-11 4 A $0.00 $0 I/I 592,866 1,049,243 0 -
HTGM Htg Molecular Diagnostics... 10% Owner   –       –       •   2015-05-11 4 A $0.00 $0 I/I 91,271 938,488 0 -
HTGM Htg Molecular Diagnostics... 10% Owner   –       –       •   2015-05-11 4 B $14.00 $5,111,484 I/I 365,106 365,106 1.5 -
HTGM Htg Molecular Diagnostics... Former 10% Owner   –       –      –    2017-03-27 4 S $10.15 $3,045,180 I/I (300,000) 792,781 0 -
INVA Innoviva Inc 10% Owner   –       –       •   2010-11-29 4 B $22.50 $129,375,000 I/I 5,750,000 5,750,000 1.5 -
INVA Innoviva Inc 10% Owner   –       –       •   2011-02-18 4 B $23.70 $3,608,989 I/I 152,278 5,902,278 1.5 -
  107  Records found
  1   2  3   4   5      
  Page 2 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us